FDA Drug Application (202015) for YAELA by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number202015
Product Number001
FormTABLET;ORAL-28
Dosage3MG;0.03MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameYAELA
Active IngredientDROSPIRENONE; ETHINYL ESTRADIOL

Active IngredientCount
List of drugs with Active Ingredient DROSPIRENONE12
List of drugs with Active Ingredient ETHINYL ESTRADIOL226


Back to FDA Applications sponsored by NOVAST LABS LTD